Clinical Quiz: AGA Guideline for Fecal Microbiota-Based Therapies in Gastrointestinal Disease

Quiz
Article

Test your knowledge of the AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases with this clinical quiz!

On February 21, 2024, the American Gastroenterological Association (AGA) released the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal diseases. A guideline panel developed 7 recommendations intended to provide the basis for rational, informed decision-making for patients and healthcare professionals using fecal microbiota-based therapies for adults with recurrent Clostridioides difficile infection (CDI), severe to fulminant CDI, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS).

In this clinical quiz, test your knowledge of the clinical recommendations for the use of fecal microbiota-based therapies in the 2024 American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.

What does the AGA suggest regarding fecal microbiota-based therapies in severely immunocompromised adults with recurrent CDI?



Reference:

  1. Peery AF, Kelly CR, Kao D, et al. American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. https://www.gastrojournal.org/article/S0016-5085(24)00041-6/fulltext
Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Hematopoietic Stem Cell Transplantation Improves Pediatric SCD Outcomes | Image Credit: Scott Graham/Unsplash
Andrew Talal, MD | Credit: University at Buffalo
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
© 2024 MJH Life Sciences

All rights reserved.